Congressional Plans for WuXi: Implications for Biotech by Lilu Anderson 29.03.2024 Stay updated on the latest in biotech with our newsletter and podcast. Boundless becomes the ninth biotech company to go ...
HealthSnap Raises $25M in Series B Funding: Revolutionizing Remote Patient Monitoring by Lilu Anderson 22.02.2024 Miami-based HealthSnap raises $25M in Series B funding for its remote patient monitoring and chronic care management solution. The company ...
Eli Lilly and Novo Nordisk Lead Pharma Surge by Mark Eisenberg 17.02.2024 The weight-loss drugs of Eli Lilly and Novo Nordisk have led to soaring share prices as investors anticipate high demand ...
The Next Trillion-Dollar Titans: Rise of Finance Giants by Mark Eisenberg 15.02.2024 A new wave of companies is racing to achieve trillion-dollar valuations, joining household names like Apple and Microsoft. Berkshire Hathaway, ...
Adial Pharmaceuticals Targets $40B Addiction Market by Mark Eisenberg 13.02.2024 Adial Pharmaceuticals acquires patent for genetic diagnostic tool to identify patients who may respond well to their lead drug AD04, ...
Assisted Reproductive Technology Market Surging $8.23B by 2027 by Mark Eisenberg 12.02.2024 The global Assisted Reproductive Technology market is projected to grow by $8.23 billion by 2027, driven by rising infertility rates ...
New Tech Tracks Brain Cells’ Off Switches by Lilu Anderson 23.01.2024 Scientists at Scripps Research have developed a breakthrough technology that allows them to track when brain cells shut off, providing ...
Wall Street Analyzes Eli Lilly’s Promising Outlook by Terry Bingman 22.01.2024 Discover the promising future for investors in Eli Lilly and Company (NYSE: LLY), a leader in the biopharmaceutical industry, with ...
Coca-Cola vs. Pepsi: Soft Drink Industry SWOT Analysis by Mark Eisenberg 21.01.2024 The soft drink industry is a battlefield for Coca-Cola and Pepsi. Let's analyze their strengths, weaknesses, opportunities, and threats in ...